CME Group Inc. (NASDAQ:CME) Stock Holdings Lessened by Cambiar Investors LLC

Cambiar Investors LLC lessened its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 1.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 284,702 shares of the financial services provider's stock after selling 3,433 shares during the quarter. CME Group makes up 2.4% of Cambiar Investors LLC's portfolio, making the stock its 3rd biggest position. Cambiar Investors LLC owned 0.08% of CME Group worth $62,819,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Capital International Investors lifted its position in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider's stock valued at $3,403,557,000 after buying an additional 3,069,806 shares during the period. PineStone Asset Management Inc. raised its position in shares of CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider's stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. M&G Plc purchased a new position in shares of CME Group in the 1st quarter worth about $156,631,000. Assenagon Asset Management S.A. raised its position in shares of CME Group by 577.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider's stock worth $126,872,000 after purchasing an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its position in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock worth $1,038,676,000 after purchasing an additional 537,758 shares during the last quarter. Institutional investors own 87.75% of the company's stock.

CME Group Stock Performance

Shares of CME Group stock traded down $1.75 during trading hours on Friday, reaching $223.61. 1,318,587 shares of the stock traded hands, compared to its average volume of 1,917,520. The company has a 50 day moving average price of $220.69 and a 200 day moving average price of $209.48. The firm has a market capitalization of $80.52 billion, a price-to-earnings ratio of 23.51, a P/E/G ratio of 5.72 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm's revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the company posted $2.25 EPS. On average, equities research analysts expect that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.06%. CME Group's dividend payout ratio (DPR) is presently 48.37%.

Insider Activity at CME Group

In related news, CFO Lynne Fitzpatrick sold 754 shares of the business's stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, Director Timothy S. Bitsberger sold 1,000 shares of the business's stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the transaction, the director now directly owns 10,589 shares of the company's stock, valued at approximately $2,403,279.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the business's stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,221 shares of company stock worth $3,351,895. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Citigroup lifted their price target on CME Group from $250.00 to $255.00 and gave the stock a "buy" rating in a research report on Thursday, October 24th. Keefe, Bruyette & Woods lifted their price target on CME Group from $212.00 to $213.00 and gave the stock a "market perform" rating in a research report on Thursday, July 25th. TD Cowen assumed coverage on CME Group in a research report on Thursday, September 26th. They issued a "hold" rating and a $221.00 price target for the company. Piper Sandler lifted their price objective on CME Group from $240.00 to $250.00 and gave the stock an "overweight" rating in a report on Monday, October 28th. Finally, Morgan Stanley lifted their price objective on CME Group from $210.00 to $233.00 and gave the stock an "equal weight" rating in a report on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, CME Group currently has an average rating of "Hold" and an average target price of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.